Polycythaemia vera

POLYCYTVERA

chronic myeloproliferative disorder: A clonal hematopoietic stem cell disorder, characterized by proliferation in the bone marrow of one or more of the myeloid (i.e., granulocytic, erythroid, megakaryocytic, and mast cell) lineages. It is primarily a neoplasm of adults. (WHO 2008)

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D45
Hospital discharge: ICD-9 2384
Hospital discharge: ICD-8 208
Cause of death: ICD-10 D45
Cause of death: ICD-9 2384
Cause of death: ICD-8 208
Cancer registry: Topography ICD-O-3 ANY
Cancer registry: Morphology ICD-O-3 9950
Cancer registry: Behaviour codes 3

3 out of 7 registries used, show all original rules.

966

diagram downward connector

Check minimum number of events None

966

diagram downward connector

Include endpoints None

966

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

942

diagram downward connector
POLYCYTVERA

Control definitions

Control exclude C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze DF8

Summary Statistics

Key figures

All Female Male
Number of individuals 942 455 487
Unadjusted prevalence (%) 0.25 0.22 0.29
Mean age at first event (years) 63.10 63.07 63.13

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.91 [1.52, 5.54] 1.2e-3 204
15 years 0.01 1.86 [1.18, 2.91] 7.3e-3 102
5 years 0.00 2.76 [1.80, 4.24] 3.0e-6 57
1 year 0.00 5.77 [3.40, 9.80] 8.1e-11 24

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: POLYCYTVERA – Polycythaemia vera
GWS hits: 9

Survival analyses between endpoints

Plot

before Polycythaemia vera
after Polycythaemia vera

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Polycythaemia vera

Endpoint not on priority list, no data to show.